Last updated: 2026-09-09 05:05:40. Prices reflect the latest closing data and will resume updating on the next trading day. Stock price data is sourced from Massive.
Integra LifeSciences Holdings (IART) operates in the SURGICAL & MEDICAL INSTRUMENTS & APPARATUS sector and is listed on NASDAQ. The stock is currently priced at $16.25, with a market capitalization of $1.30B and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $8.70 to $20.49. This page covers its latest market performance, valuation, price trends and company information.
$1.30B | |
$16.48 | |
$77.40 | |
$8.70 | |
$16.72 | |
498.91K | |
857.32K | |
-- | |
$20.49 | |
$8.70 | |
-- | |
-- |
Integra LifeSciences Holdings (IART) last closed at $16.72 as of 2026-09-08 23:31:00, unchanged from the previous close of $16.72.
During the latest regular trading session, IART traded between $8.70 and $77.40, with a volume of 498.91K shares. The closing price was near the lower end and near the middle of its 52-week range.
Over the past seven days, Integra LifeSciences Holdings (IART) moved from $16.85 to $16.25, representing a decline of 3.55% ($0.60).
The stock traded between $15.99 and $17.33 during the period. The latest price is near the lower end of the 7-day range, indicating moderate downward.
The average daily volume was 652.71 thousand shares, up versus the previous seven-day period, indicating higher trading activity.
Position in Range: 64.0%
IART is currently trading at $16.25, placing it 64.0% of the way from its 52-week low of $8.70 to its 52-week high of $20.49. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
Integra Lifesciences Holdings Corp is a New Jersey-based medical equipment company focused on developing products for regenerative therapy, extremity orthopedics, and neurosurgical applications. The firm is organized into two primary segments: Codman specialty surgical and Tissue technologies. Codman Specialty Surgical generates maximum revenue from its segmental operations. Integra serves Europe, Asia Pacific, and the rest of the world whilst it derives key revenue from domestic sales. The company operates in United States, Europe, Asia Pacific, and Rest of the World.
| Industry | SURGICAL & MEDICAL INSTRUMENTS & APPARATUS |
| Employees | 4427 |
| Exchange | NASDAQ |
| Company Website |
Eligible investors can buy real shares of Integra LifeSciences Holdings (IART) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.